| http://www.w3.org/ns/prov#value | - In October the company launched HyQSphere microcarriers for adherent cell lines, aimed at optimizing scale-up for such cell lines as Vero and MDCK cells used in viral vaccine production.Developed in collaboration with Baxter Biosciences (www. baxter.com), HyClone's Single-Use Bioreactor, designed for scalable mammalian cell culture in working volumes of 50 L to 1000 L will come to the market in Ap
|
